Sun Pharma Advanced Research Company posts Q4 net loss of Rs 56.72 cr
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
The company reported standalone net loss during the quarter stood at Rs 56.72 crore as compared to net loss of Rs 99.54 crore in the previous year quarter. Net revenue of the company rose substantially by 23.56 per cent at Rs 28.06 crore in January-March quarter of this fiscal as against Rs 22.71 crore in the corresponding period last year.
During January-March quarter, operating expenses dropped by 35.17 per cent to Rs 78.49 crore from Rs 121.07 crore in year ago period. Other Income dipped by 89.42 per cent at Rs 0.33 crore versus (Mar'20 Rs 3.12 crore).
Operating Profit slipped by 48.73 per cent to Rs -50.43 crore as against Rs -98.36 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 58.50 per cent in March quarter. Interest grew by 156.05 per cent y-o-y to Rs 4.02 crore
